WCA
BSX icon

Westover Capital Advisors’s Boston Scientific BSX Stock Holding History

Westover Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,447
Closed -$342K – 245
2026
Q1 		$342K Buy
5,447
+72
+1% +$5.76K 0.06% 182
2025
Q4 		$513K Sell
5,375
-10,486
-66% -$1.03M 0.09% 149
2025
Q3 		$1.55M Buy
15,861
+1,282
+9% +$133K 0.29% 68
2025
Q2 		$1.57M Buy
14,579
+841
+6% +$85.1K 0.31% 69
2025
Q1 		$1.39M Sell
13,738
-934
-6% -$94K 0.31% 73
2024
Q4 		$1.31M Sell
14,672
-399
-3% -$35.1K 0.29% 82
2024
Q3 		$1.26M Sell
15,071
-825
-5% -$65K 0.24% 88
2024
Q2 		$1.22M Sell
15,896
-1,156
-7% -$84.6K 0.32% 82
2024
Q1 		$1.17M Buy
17,052
+1,620
+10% +$104K 0.34% 74
2023
Q4 		$892K Sell
15,432
-231
-1% -$12.3K 0.29% 82
2023
Q3 		$827K Sell
15,663
-475
-3% -$24.9K 0.3% 77
2023
Q2 		$873K Sell
16,138
-1,120
-6% -$58.5K 0.3% 79
2023
Q1 		$863K Sell
17,258
-1,300
-7% -$61.3K 0.32% 74
2022
Q4 		$859K Sell
18,558
-100
-0.5% -$4.33K 0.34% 73
2022
Q3 		$723K Buy
18,658
+666
+4% +$26.7K 0.28% 81
2022
Q2 		$671K Sell
17,992
-10
-0.1% -$407 0.25% 82
2022
Q1 		$797K Buy
18,002
+10,925
+154% +$473K 0.25% 84
2021
Q4 		$301K Buy
7,077
+1,370
+24% +$57.6K 0.09% 149
2021
Q3 		$248K Buy
5,707
+819
+17% +$36.2K 0.08% 155
2021
Q2 		$209K Buy
+4,888
New +$206K 0.07% 176
2020
Q2 		– Sell
-8,988
Closed -$293K – 112
2020
Q1 		$293K Sell
8,988
-801
-8% -$31.3K 0.16% 91
2019
Q4 		$443K Sell
9,789
-340
-3% -$14.2K 0.2% 93
2019
Q3 		$412K Sell
10,129
-220
-2% -$9.32K 0.19% 92
2019
Q2 		$445K Sell
10,349
-353
-3% -$13.6K 0.22% 83
2019
Q1 		$411K Sell
10,702
-50
-0.5% -$1.91K 0.21% 81
2018
Q4 		$380K Buy
+10,752
New +$390K 0.24% 77

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westover Capital Advisors's BSX Position: Q2 2026 in Review

Westover Capital Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 5,447 shares — an estimated $342K sold.

Westover Capital Advisors first reported a position in BSX in Q4 2018 and held it in 26 quarters. The position peaked at $1.57M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Westover Capital Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Westover Capital Advisors sold 5,447 Boston Scientific shares in Q2 2026, an estimated $342K.
  • Westover Capital Advisors first reported a position in Boston Scientific in Q4 2018 and held it in 26 quarters.
  • Westover Capital Advisors's Boston Scientific position peaked at $1.57M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Westover Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.